Reasoning
The ClinGen PTEN VCEP permits PS4 for a sufficiently powered case-control study when the odds ratio is >2, p<0.05, and the 95% confidence-interval lower limit is >1.5; it also permits phenotype-specific scoring of independent probands, with 1 point for an adult Cleveland Clinic score >=30, 0.5 for 25-29, 1 point for a child pediatric phenotype score >=5, or 0.5 for a score of 4. No affected-proband phenotype scores, variant-carrier case counts, unaffected-control counts, or case-control statistics are available here. literature_pass.json contains no packet.ai_classified_papers entries to verify, and the available literature packet contains only general functional papers without variant-specific case-control or phenotype-specific evidence. gnomAD v2.1, v4.1, and Canada report the variant as absent, so the VCEP condition that PS4 may not be applied if BS1 applies is not triggered; however, absence in population databases alone does not satisfy the VCEP PS4 rule. The governing case-control operator is the VCEP's literal >2 condition: no observed odds ratio is available, so no substituted inequality can be evaluated and PS4 remains not_assessed.
VCEP rule
This criterion may not be applied if BS1 applies. Phenotype specificity scores are added across independent probands and calculated as follows: ... PS4\_Very Strong: Probands with specificity score ≥16. PS4: Probands with specificity score of 4-15.5. PS4\_Moderate: Probands with specificity score of 2-3.5. PS4\_Supporting: Proband(s) with specificity score of 1-1.5. ... However, if sufficiently powered, a case-control study finding an odds ratio >2 for a PHTS component phenotype with p<0.05 and 95% confidence interval with lower limit >1.5, this criteria may be applied.
Evidence considered
- ClinGen PTEN VCEP PS4 rule: a sufficiently powered case-control study may apply PS4 when the odds ratio is >2, p<0.05, and the 95% confidence-interval lower limit is >1.5; the VCEP also specifies phenotype-specificity scoring across independent probands.
- The VCEP PS4 rule states that PS4 may not be applied if BS1 applies; gnomAD v2.1, gnomAD v4.1, and gnomAD-Canada each report NM_000314.8:c.786del as absent, with no BS1-range frequency shown.
- The literature packet has total_pmids=2, ai_classified_papers=[], and no criterion-screened variant-specific case-control or phenotype-specific findings; the two listed papers are general PTEN functional papers.
Still missing
- Affected-proband counts and matched unaffected-control counts for NM_000314.8:c.786del, or a reported odds ratio with p value and 95% confidence interval.
- Independent proband phenotype data sufficient to calculate Cleveland Clinic or pediatric phenotype specificity scores.
Sources